Recent publications

HBV RNaseH as a promising antiviral target

The Tavis lab makes the case for the Hepatitis B virus RNaseH as a very promising target for new inhibitors that will completely cure chronic HBV infections. The manuscript “Shedding light on RNaseH: a promising target for hepatitis V virus HBV)was published in “Expert Opinion in Therapeutic Targets on May 13, 2019.

Current members of the Tavis Lab